Zhejiang Er Ying Pharmaceutical

Zhejiang Erying Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and high-end pharmaceutical intermediates. The company operates advanced manufacturing facilities that comply with international GMP standards, serving both domestic and global markets. Their product portfolio primarily focuses on therapeutic areas such as cardiovascular health, anti-infectives, and the central nervous system. Erying Pharmaceutical provides CDMO services, supporting drug development from laboratory scale to commercial production. The company is recognized as a high-tech enterprise in Zhejiang province and focuses on complex chemical synthesis and purification technologies. They are known for producing key cardiovascular and antidiabetic agents like Rosuvastatin and Sitagliptin.